References
- Hoffman A. Pharmacodynamic aspects of sustained release preparations. Adv Drug Deliv Rev 1998;33:185–199.
- Chawla G, Gupta P, Koradia V, Bansal AK. Gastroretention: A means to address regional variability in intestinal drug absorption. Pharm Tech July 2003:50–68.
- Hwang SJ, Park H, Park K. Gastric retentive drug-delivery systems. Crit Rev Ther Drug Carrier Syst 1998;15:243–284.
- Hoffman A, Stepensky D. Pharmacodynamic aspects of modes of drug administration for optimization of drug therapy. Crit Rev Ther Drug Carrier Syst 1999;16:571–639.
- Deshpande AA, Rhodes CT, Shah NH, Malick W. Controlled-release drug delivery systems for prolonged gastric residence: An overview. Drug Dev Ind Pharm 1996;22:531–539.
- Singh BN, Kim KH. Floating drug delivery systems: an approach to oral controlled drug delivery via gastric retention. J Control Release 2000;63:235–259.
- Moës AJ. Gastroretentive dosage forms. Crit Rev Ther Drug Carrier Syst 1993;10:143–195.
- Rubinstein A, Friend DR. (1994). Specific delivery to the gastrointestinal tract. In: Domb AJ ed. Polymeric Site-Specific Pharmacotherapy. Wiley, Chichester 267–313.
- Mamjek RC, Moyer ES. inventors. Mc Neilab, Inc, assignee. Drug Dispensing Device and Method. US Patent, June 17, 1980; No. 4 207 890.
- McEvoy GK. (2004). Cephalosporins: cefuroxime sodium and cefuroxime axetil. In: AHFS Drug Information. Bethesda: American Society of Hospital Pharmacists, 99–108.
- Sommers DK, van Wyk M, Moncrieff J, Schoeman HS. Influence of food and reduced gastric acidity on the bioavailability of bacampicillin and cefuroxime axetil. Br J Clin Pharmacol 1984;18:535–539.
- Indian Pharmacopoeia. The controller of publications: Delhi, Vol. II, 1996:734–736.
- Banker GS, Anderson NR. (1987). Tablets. In: Lachmann L, Liberman HA, Kanig JL, eds. The Theory and practice of industrial pharmacy. 3rd ed. Mumbai: Varghese publishing house, 297–299.
- Baumgartner S, Kristl J, Vrecer F, Vodopivec P, Zorko B. Optimisation of floating matrix tablets and evaluation of their gastric residence time. Int J Pharm 2000;195:125–135.
- Wagner JG. Interpretation of percent dissolved-time plots derived from in vitro testing of conventional tablets and capsules. J Pharm Sci 1969;58:1253–1257.
- Higuchi T. Mechanism of sustained-action medication: Theoretical analysis of rate of release of solid drugs dispersed in solid matrices. J Pharm Sci 1963;52:1145–1149.
- Korsmeyer RW, Gurny R, Doelker E, Buri P, Peppas NA. Mechanisms of solute release from porous hydrophilic polymers. Int J Pharm 1983;15:25–35.
- Peppas NA. Analysis of Fickian and non-Fickian drug release from polymers. Pharm Acta Helv 1985;60:110–111.
- Siepmann J, Peppas NA. Modeling of drug release from delivery systems based on hydroxypropyl methylcellulose (HPMC). Adv Drug Deliv Rev 2001;48:139–157.
- Ruiz-Carretero P, Nacher A, Merino-Sanjuan M, Casabo VG. Pharmacokinetics and absolute bioavailability of oral cefuroxime axetil in the rat. Int J Pharm 2000;202:89–96.
- Shargel L, Pong SW, Yu ABC. (2005). Applied biopharmaceutics and pharmacokinetics. 5th ed. New York: Mc Graw Hill, 435–475, 169–176.
- Jaimini M, Rana AC, Tanwar YS. Formulation and evaluation of famotidine floating tablets. Curr Drug Deliv 2007;4:51–55.
- Chiao CSL, Robinson JR.. (2000). Sustained-release drug delivery systems. In: Gennaro AR. ed. Remington: The Science and Practice of Pharmacy. 19th ed. Vol. 2, Lippincott, Williams and Wilkins, Philadelphia, 1660–1675.
- Bomma R, Swamy Naidu RA, Yamsani MR, Veerabrahma K. Development and evaluation of gastroretentive norfloxacin floating tablets. Acta Pharm 2009;59:211–221.
- Guguloth M, Bomma R, Veerabrahma K. Development of sustained release floating drug delivery system for norfloxacin: In vitro and in vivo evaluation. PDA J Pharm Sci and Tech 2011;65:198–206.